about
The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen PoreValidation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruziATP Binding Cassette Transporter Mediates Both Heme and Pesticide Detoxification in Tick Midgut CellsExtracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host AnemiaEnhancing glycan isomer separations with metal ions and positive and negative polarity ion mobility spectrometry-mass spectrometry analyses.Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.Characterization of the small RNA content of Trypanosoma cruzi extracellular vesicles.A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas diseaseLipidomic analysis of extracellular vesicles from the pathogenic phase of Paracoccidioides brasiliensis.Therapeutic administration of recombinant Paracoccin confers protection against paracoccidioides brasiliensis infection: involvement of TLRs.Extracellular vesicles in parasitic diseasesLysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation.Recognition of TLR2 N-glycans: critical role in ArtinM immunomodulatory activity.Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.Molecular Characterization of a Novel Family of Trypanosoma cruzi Surface Membrane Proteins (TcSMP) Involved in Mammalian Host Cell Invasion.Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi.Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues.Characterization of Lipids and Proteins Associated to the Cell Wall of the Acapsular Mutant Cryptococcus neoformans Cap 67.Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.Identification of human plasma proteins associated with the cell wall of the pathogenic fungus Paracoccidioides brasiliensis.The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles.The impact of acute brain dysfunction in the outcomes of mechanically ventilated cancer patients.Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic settingDifferent proteomic strategies to identify genuine Small Ubiquitin-like MOdifier targets and their modification sites in Trypanosoma brucei procyclic forms.Detection of high levels of anti-α-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting.Virus-like Particle Display of the α-Gal Epitope for the Diagnostic Assessment of Chagas Disease.Sterol targeting drugs reveal life cycle stage-specific differences in trypanosome lipid raftsCompositional and immunobiological analyses of extracellular vesicles released by Candida albicans.Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins.Environmental Effects of Nanoceria on Seed Production of Common Bean (Phaseolus vulgaris): A Proteomic Analysis.An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.Dynamic flux of microvesicles modulate parasite-host cell interaction of Trypanosoma cruzi in eukaryotic cells.Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas diseaseA prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
P50
Q28548647-2166FC9C-AEFB-46E2-A696-AA860064FD9DQ28551708-59C15FF4-F1C2-4721-8A82-9D8C75F2A77BQ28630458-F1CEEDB3-497E-471D-8F97-91CC01A5FB79Q30698901-CC734276-F41A-4243-808E-E2A913EB70C7Q33698046-F43689D9-3F53-4FA2-B1D8-669F9897FE47Q33743568-B856E75F-F924-49D1-A724-3A0B356A20E5Q33760091-5B762F33-B0C7-40DD-88F1-5119A033BCDEQ33760119-D280D5B1-4DF2-4A3A-B493-E0465C15F662Q34321418-DC642DD5-6C41-4CE5-8FBC-7433BAA423E2Q34633989-8A9EC644-A66E-4876-97A4-52F1E4CCC7C0Q34767634-0FCECDC3-4294-43F5-AAFE-626E1003D547Q35061594-360A3BFF-E1BD-4B70-BB24-F4222D98532AQ35180695-38DD8F95-086D-4794-89CC-E02B028E9008Q35810790-99CA59CD-F638-4428-89A9-BDC2EDC26CCEQ35840717-4207498D-0EE7-41EC-AD53-E90AD04C46A5Q35869182-B9D42F65-A3E0-40F0-BEC5-2AD641EF553BQ36080155-2782ABEC-1AB8-4DF4-9DBE-FA2CA767AFB1Q36208572-68CF53C7-533C-4975-A449-D09CA5DEE7D2Q36353119-DF76370A-2F57-47ED-9B48-61321D01AABBQ36747139-39E3D8DD-A017-45BE-A78B-AF679E2B36E5Q37100258-E589F796-446B-40EE-A770-74A5E0E165FDQ37504963-5E993746-D254-4598-A566-86602ADE43C5Q38567777-E46D282E-7529-467D-822B-AEBCCEB8BBABQ38861550-F84279C2-38A9-4FCC-9307-0199437F0F81Q38866625-F672F172-D6D9-428A-9C16-5A18DC26F140Q40518894-48CAB291-195F-4BDC-B020-1E87BD04DC81Q41490508-EF9FC38E-3913-42AD-9643-896EFAE93E12Q41714104-621086C5-BAE3-498A-B8D1-68ABF8800308Q44316258-B8565098-80CB-4367-81D3-394C21150D69Q45290800-CF2EFD1E-871A-4630-B63C-EB7FDB298DBBQ46275091-4A05A538-4899-4E9F-9942-FD8E9DB417EAQ47708871-6D9E854E-9D34-44B8-B4CD-CB360463B3C0Q51465641-878EF75F-A7E9-4C30-8338-7698EC95B0ACQ56778835-0A9E6665-767D-41A9-9E14-0A9F3EB71110Q64063181-D30E611C-027A-4E67-8A0A-A362D2408817
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Igor C Almeida
@ast
Igor C Almeida
@en
Igor C Almeida
@es
Igor C Almeida
@nl
type
label
Igor C Almeida
@ast
Igor C Almeida
@en
Igor C Almeida
@es
Igor C Almeida
@nl
prefLabel
Igor C Almeida
@ast
Igor C Almeida
@en
Igor C Almeida
@es
Igor C Almeida
@nl
P106
P21
P31
P496
0000-0002-2443-8213